Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other Accumulated Expenses (2020 - 2025)

Journey Medical (DERM) has disclosed Other Accumulated Expenses for 6 consecutive years, with $755000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses rose 104.05% year-over-year to $755000.0, compared with a TTM value of $755000.0 through Sep 2025, up 104.05%, and an annual FY2024 reading of $448000.0, up 129.74% over the prior year.
  • Other Accumulated Expenses was $755000.0 for Q3 2025 at Journey Medical, down from $840000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.7 million in Q1 2022 and bottomed at $195000.0 in Q4 2023.
  • Average Other Accumulated Expenses over 5 years is $812647.1, with a median of $603000.0 recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses plummeted 75.32% in 2023, then skyrocketed 223.08% in 2025.
  • Year by year, Other Accumulated Expenses stood at $450000.0 in 2021, then decreased by 8.22% to $413000.0 in 2022, then crashed by 52.78% to $195000.0 in 2023, then surged by 129.74% to $448000.0 in 2024, then soared by 68.53% to $755000.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for DERM at $755000.0 in Q3 2025, $840000.0 in Q2 2025, and $720000.0 in Q1 2025.